In response to yesterday’s Anecdote #35: “I’ve noticed…a dramatic reduction in my psoriasis” (Link), my friend Jeff Gilligan commented that he too enjoyed a similar experience after taking NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews). Here’s what he said:
Category: Psoriasis
This is not the first time we’ve heard from someone claiming that vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews) helped treat psoriasis. Gary Varvaro told us the same (Link). Some might find these claims plausible considering we’ve also heard from many others reporting remarkable skin benefits after taking NR (Link). Of course, until we have positive results from human clinical trials, we won’t know whether these claims have any credibility. That said, here is yet another powerful personal experience submitted to us by NR consumer Lawrence Lane:
Many consumers have reported their skin transformed by vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews). Some of the most striking examples: Gary’s psoriasis, Anne’s facial spots, and Mike’s younger and smoother skin. (This may explain why there’s a relatively new NR skin care product on the market.) In our latest reader submission, a 44 year-old female whose initials are LP explains in great detail how she believes NR has changed her life (please consider sharing your own NAD+ supplement experience below):
Last week, we heard from Gary Varvaro who believes Nicotinamide Riboside “NR” (FAQs) (Reviews) helped cure his Psoriasis. Now comes a story from Donna about a friend suffering from Alopecia (see below). These anecdotes appear to add more credibility to the belief that NR can play a role in impacting those suffering from autoimmune diseases (please consider sharing your own NAD+ supplement experience below).
Last year, the NIH launched a pilot study “to test if the dietary supplement Nicotinamide Riboside “NR” (FAQs) (Reviews) can improve immune system function in the blood and skin of people with mild to moderate psoriasis”. According to the study’s principal investigator Dr. Michael Sack, “as the disease (psoriasis) gets more advanced, it can affect the joints, so you can get arthritis. The chronic inflammation can have systemic effects. We’re trying to see in the mild to moderate disease range whether we can prevent (these effects on the entire body)”. The NIH study is expected to be completed on September 30, 2023. In the meantime, we’re fortunate to have the following remarkable submission received yesterday (please consider sharing your own NAD+ supplement experience below):